시장조사 보고서 : 세계의 펩타이드 CDMO 시장예측 2021년-2026년

■ 영문 제목 : Global Peptide CDMO Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02264 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 113 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 펩타이드 CDMO의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (LPPS, SPPS, 혼합상)와 용도별 시장규모 (제약 산업, 화장품 산업, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 펩타이드 CDMO 시장 점유율
- 지역별 펩타이드 CDMO 시장규모
- 주요지역의 종류별 시장규모 (LPPS, SPPS, 혼합상)
- 주요지역의 용도별 시장규모 (제약 산업, 화장품 산업, 기타)
- 미주의 펩타이드 CDMO 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 펩타이드 CDMO 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 펩타이드 CDMO 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 펩타이드 CDMO 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 펩타이드 CDMO 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Thermo Fisher Pharma, PolyPeptide, Bachem, ScinoPharm, CBL, AmbioPharm, Piramal Pharma, CordenPharma, CPC SCIENTIFIC, Provepharm, Space Peptides, Biopeptek, Alpha Biophama, Alabiochem, Aurigene Pharmaceutical Services, Chengdu Shengnuo Biotechnology Co., Ltd, Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Peptide CDMO will have significant change from previous year. By the most conservative estimates of global Peptide CDMO market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Peptide CDMO market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide CDMO market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
LPPS
SPPS
Mixed Phase

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Pharmaceutical Industry
Cosmetics Industry
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher Pharma
PolyPeptide
Bachem
ScinoPharm
CBL
AmbioPharm
Piramal Pharma
CordenPharma
CPC SCIENTIFIC
Provepharm
Space Peptides
Biopeptek
Alpha Biophama
Alabiochem
Aurigene Pharmaceutical Services
Chengdu Shengnuo Biotechnology Co., Ltd
Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peptide CDMO Market Size 2016-2026
2.1.2 Peptide CDMO Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Peptide CDMO Segment by Type
2.2.1 LPPS
2.2.2 LPPS
2.2.3 Mixed Phase
2.3 Peptide CDMO Market Size by Type
2.3.1 Global Peptide CDMO Market Size CAGR by Type
2.3.2 Global Peptide CDMO Market Size Market Share by Type (2016-2021)
2.4 Peptide CDMO Segment by Application
2.4.1 Pharmaceutical Industry
2.4.2 Cosmetics Industry
2.4.3 Others
2.5 Peptide CDMO Market Size by Application
2.5.1 Global Peptide CDMO Market Size CAGR by Application
2.5.2 Global Peptide CDMO Market Size Market Share by Application (2016-2021)

3 Peptide CDMO Market Size by Players
3.1 Peptide CDMO Market Size Market Share by Players
3.1.1 Global Peptide CDMO Revenue by Players (2019-2021E)
3.1.2 Global Peptide CDMO Revenue Market Share by Players (2019-2021E)
3.2 Global Peptide CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Peptide CDMO by Regions
4.1 Peptide CDMO Market Size by Regions (2016-2021)
4.2 Americas Peptide CDMO Market Size Growth (2016-2021)
4.3 APAC Peptide CDMO Market Size Growth (2016-2021)
4.4 Europe Peptide CDMO Market Size Growth (2016-2021)
4.5 Middle East & Africa Peptide CDMO Market Size Growth (2016-2021)

5 Americas
5.1 Americas Peptide CDMO Market Size by Country (2016-2021)
5.2 Americas Peptide CDMO Market Size by Type (2016-2021)
5.3 Americas Peptide CDMO Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Peptide CDMO Market Size by Region (2016-2021)
6.2 APAC Peptide CDMO Market Size by Type (2016-2021)
6.3 APAC Peptide CDMO Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Peptide CDMO by Country (2016-2021)
7.2 Europe Peptide CDMO Market Size by Type (2016-2021)
7.3 Europe Peptide CDMO Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Peptide CDMO by Region (2016-2021)
8.2 Middle East & Africa Peptide CDMO Market Size by Type (2016-2021)
8.3 Middle East & Africa Peptide CDMO Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Peptide CDMO Market Forecast
10.1 Global Peptide CDMO Forecast by Regions (2021-2026)
10.1.1 Global Peptide CDMO Forecast by Regions (2021-2026)
10.1.2 Americas Peptide CDMO Forecast
10.1.3 APAC Peptide CDMO Forecast
10.1.4 Europe Peptide CDMO Forecast
10.1.5 Middle East & Africa Peptide CDMO Forecast
10.2 Americas Peptide CDMO Forecast by Countries (2021-2026)
10.2.1 United States Peptide CDMO Market Forecast
10.2.2 Canada Peptide CDMO Market Forecast
10.2.3 Mexico Peptide CDMO Market Forecast
10.2.4 Brazil Peptide CDMO Market Forecast
10.3 APAC Peptide CDMO Forecast by Region (2021-2026)
10.3.1 China Peptide CDMO Market Forecast
10.3.2 Japan Peptide CDMO Market Forecast
10.3.3 Korea Peptide CDMO Market Forecast
10.3.4 Southeast Asia Peptide CDMO Market Forecast
10.3.5 India Peptide CDMO Market Forecast
10.3.6 Australia Peptide CDMO Market Forecast
10.4 Europe Peptide CDMO Forecast by Country (2021-2026)
10.4.1 Germany Peptide CDMO Market Forecast
10.4.2 France Peptide CDMO Market Forecast
10.4.3 UK Peptide CDMO Market Forecast
10.4.4 Italy Peptide CDMO Market Forecast
10.4.5 Russia Peptide CDMO Market Forecast
10.5 Middle East & Africa Peptide CDMO Forecast by Region (2021-2026)
10.5.1 Egypt Peptide CDMO Market Forecast
10.5.2 South Africa Peptide CDMO Market Forecast
10.5.3 Israel Peptide CDMO Market Forecast
10.5.4 Turkey Peptide CDMO Market Forecast
10.5.5 GCC Countries Peptide CDMO Market Forecast
10.6 Global Peptide CDMO Forecast by Type (2021-2026)
10.7 Global Peptide CDMO Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Thermo Fisher Pharma
11.1.1 Thermo Fisher Pharma Company Information
11.1.2 Thermo Fisher Pharma Peptide CDMO Product Offered
11.1.3 Thermo Fisher Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Thermo Fisher Pharma Main Business Overview
11.1.5 Thermo Fisher Pharma Latest Developments
11.2 PolyPeptide
11.2.1 PolyPeptide Company Information
11.2.2 PolyPeptide Peptide CDMO Product Offered
11.2.3 PolyPeptide Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 PolyPeptide Main Business Overview
11.2.5 PolyPeptide Latest Developments
11.3 Bachem
11.3.1 Bachem Company Information
11.3.2 Bachem Peptide CDMO Product Offered
11.3.3 Bachem Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Bachem Main Business Overview
11.3.5 Bachem Latest Developments
11.4 ScinoPharm
11.4.1 ScinoPharm Company Information
11.4.2 ScinoPharm Peptide CDMO Product Offered
11.4.3 ScinoPharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 ScinoPharm Main Business Overview
11.4.5 ScinoPharm Latest Developments
11.5 CBL
11.5.1 CBL Company Information
11.5.2 CBL Peptide CDMO Product Offered
11.5.3 CBL Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 CBL Main Business Overview
11.5.5 CBL Latest Developments
11.6 AmbioPharm
11.6.1 AmbioPharm Company Information
11.6.2 AmbioPharm Peptide CDMO Product Offered
11.6.3 AmbioPharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 AmbioPharm Main Business Overview
11.6.5 AmbioPharm Latest Developments
11.7 Piramal Pharma
11.7.1 Piramal Pharma Company Information
11.7.2 Piramal Pharma Peptide CDMO Product Offered
11.7.3 Piramal Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Piramal Pharma Main Business Overview
11.7.5 Piramal Pharma Latest Developments
11.8 CordenPharma
11.8.1 CordenPharma Company Information
11.8.2 CordenPharma Peptide CDMO Product Offered
11.8.3 CordenPharma Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 CordenPharma Main Business Overview
11.8.5 CordenPharma Latest Developments
11.9 CPC SCIENTIFIC
11.9.1 CPC SCIENTIFIC Company Information
11.9.2 CPC SCIENTIFIC Peptide CDMO Product Offered
11.9.3 CPC SCIENTIFIC Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 CPC SCIENTIFIC Main Business Overview
11.9.5 CPC SCIENTIFIC Latest Developments
11.10 Provepharm
11.10.1 Provepharm Company Information
11.10.2 Provepharm Peptide CDMO Product Offered
11.10.3 Provepharm Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Provepharm Main Business Overview
11.10.5 Provepharm Latest Developments
11. Space Peptides
11.11.1 Space Peptides Company Information
11.11.2 Space Peptides Peptide CDMO Product Offered
11.11.3 Space Peptides Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Space Peptides Main Business Overview
11.11.5 Space Peptides Latest Developments
11.12 Biopeptek
11.12.1 Biopeptek Company Information
11.12.2 Biopeptek Peptide CDMO Product Offered
11.12.3 Biopeptek Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Biopeptek Main Business Overview
11.12.5 Biopeptek Latest Developments
11.13 Alpha Biophama
11.13.1 Alpha Biophama Company Information
11.13.2 Alpha Biophama Peptide CDMO Product Offered
11.13.3 Alpha Biophama Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Alpha Biophama Main Business Overview
11.13.5 Alpha Biophama Latest Developments
11.14 Alabiochem
11.14.1 Alabiochem Company Information
11.14.2 Alabiochem Peptide CDMO Product Offered
11.14.3 Alabiochem Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Alabiochem Main Business Overview
11.14.5 Alabiochem Latest Developments
11.15 Aurigene Pharmaceutical Services
11.15.1 Aurigene Pharmaceutical Services Company Information
11.15.2 Aurigene Pharmaceutical Services Peptide CDMO Product Offered
11.15.3 Aurigene Pharmaceutical Services Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Aurigene Pharmaceutical Services Main Business Overview
11.15.5 Aurigene Pharmaceutical Services Latest Developments
11.16 Chengdu Shengnuo Biotechnology Co., Ltd
11.16.1 Chengdu Shengnuo Biotechnology Co., Ltd Company Information
11.16.2 Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Product Offered
11.16.3 Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Chengdu Shengnuo Biotechnology Co., Ltd Main Business Overview
11.16.5 Chengdu Shengnuo Biotechnology Co., Ltd Latest Developments
11.17 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd
11.17.1 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Company Information
11.17.2 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Product Offered
11.17.3 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Main Business Overview
11.17.5 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Peptide CDMO Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of LPPS
Table 3. Major Players of SPPS
Table 4. Major Players of Mixed Phase
Table 5. Peptide CDMO Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Peptide CDMO Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Peptide CDMO Market Size Market Share by Type (2016-2021)
Table 8. Peptide CDMO Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Peptide CDMO Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Peptide CDMO Market Size Market Share by Application (2016-2021)
Table 11. Global Peptide CDMO Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Peptide CDMO Revenue Market Share by Players (2019-2021E)
Table 13. Peptide CDMO Key Players Head office and Products Offered
Table 14. Peptide CDMO Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peptide CDMO Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Peptide CDMO Market Size Market Share by Regions 2016-2021
Table 19. Americas Peptide CDMO Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Peptide CDMO Market Size Market Share by Country (2016-2021)
Table 21. Americas Peptide CDMO Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Peptide CDMO Market Size Market Share by Type (2016-2021)
Table 23. Americas Peptide CDMO Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Peptide CDMO Market Size Market Share by Application (2016-2021)
Table 25. APAC Peptide CDMO Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Peptide CDMO Market Size Market Share by Region (2016-2021)
Table 27. APAC Peptide CDMO Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Peptide CDMO Market Size Market Share by Type (2016-2021)
Table 29. APAC Peptide CDMO Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Peptide CDMO Market Size Market Share by Application (2016-2021)
Table 31. Europe Peptide CDMO Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Peptide CDMO Market Size Market Share by Country (2016-2021)
Table 33. Europe Peptide CDMO Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Peptide CDMO Market Size Market Share by Type (2016-2021)
Table 35. Europe Peptide CDMO Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Peptide CDMO Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Peptide CDMO Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Peptide CDMO Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Peptide CDMO Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Peptide CDMO Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Peptide CDMO Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Peptide CDMO Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Peptide CDMO
Table 44. Key Application and Potential Industries of Peptide CDMO
Table 45. Key Challenges of Peptide CDMO
Table 46. Key Trends of Peptide CDMO
Table 47. Global Peptide CDMO Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Peptide CDMO Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Peptide CDMO Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Peptide CDMO Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Peptide CDMO Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Peptide CDMO Market Size Market Share Forecast by Application (2021-2026)
Table 53. Thermo Fisher Pharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 54. Thermo Fisher Pharma Peptide CDMO Product Offered
Table 55. Thermo Fisher Pharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Thermo Fisher Pharma Main Business
Table 57. Thermo Fisher Pharma Latest Developments
Table 58. PolyPeptide Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 59. PolyPeptide Peptide CDMO Product Offered
Table 60. PolyPeptide Main Business
Table 61. PolyPeptide Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. PolyPeptide Latest Developments
Table 63. Bachem Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 64. Bachem Peptide CDMO Product Offered
Table 65. Bachem Main Business
Table 66. Bachem Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Bachem Latest Developments
Table 68. ScinoPharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 69. ScinoPharm Peptide CDMO Product Offered
Table 70. ScinoPharm Main Business
Table 71. ScinoPharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. ScinoPharm Latest Developments
Table 73. CBL Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 74. CBL Peptide CDMO Product Offered
Table 75. CBL Main Business
Table 76. CBL Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. CBL Latest Developments
Table 78. AmbioPharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 79. AmbioPharm Peptide CDMO Product Offered
Table 80. AmbioPharm Main Business
Table 81. AmbioPharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. AmbioPharm Latest Developments
Table 83. Piramal Pharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 84. Piramal Pharma Peptide CDMO Product Offered
Table 85. Piramal Pharma Main Business
Table 86. Piramal Pharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Piramal Pharma Latest Developments
Table 88. CordenPharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 89. CordenPharma Peptide CDMO Product Offered
Table 90. CordenPharma Main Business
Table 91. CordenPharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. CordenPharma Latest Developments
Table 93. CPC SCIENTIFIC Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 94. CPC SCIENTIFIC Peptide CDMO Product Offered
Table 95. CPC SCIENTIFIC Main Business
Table 96. CPC SCIENTIFIC Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. CPC SCIENTIFIC Latest Developments
Table 98. Provepharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 99. Provepharm Peptide CDMO Product Offered
Table 100. Provepharm Main Business
Table 101. Provepharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Provepharm Latest Developments
Table 103. Space Peptides Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 104. Space Peptides Peptide CDMO Product Offered
Table 105. Space Peptides Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Space Peptides Main Business
Table 107. Space Peptides Latest Developments
Table 108. Biopeptek Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 109. Biopeptek Peptide CDMO Product Offered
Table 110. Biopeptek Main Business
Table 111. Biopeptek Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 112. Biopeptek Latest Developments
Table 113. Alpha Biophama Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 114. Alpha Biophama Peptide CDMO Product Offered
Table 115. Alpha Biophama Main Business
Table 116. Alpha Biophama Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 117. Alpha Biophama Latest Developments
Table 118. Alabiochem Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 119. Alabiochem Peptide CDMO Product Offered
Table 120. Alabiochem Main Business
Table 121. Alabiochem Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 122. Alabiochem Latest Developments
Table 123. Aurigene Pharmaceutical Services Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 124. Aurigene Pharmaceutical Services Peptide CDMO Product Offered
Table 125. Aurigene Pharmaceutical Services Main Business
Table 126. Aurigene Pharmaceutical Services Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 127. Aurigene Pharmaceutical Services Latest Developments
Table 128. Chengdu Shengnuo Biotechnology Co., Ltd Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 129. Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Product Offered
Table 130. Chengdu Shengnuo Biotechnology Co., Ltd Main Business
Table 131. Chengdu Shengnuo Biotechnology Co., Ltd Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 132. Chengdu Shengnuo Biotechnology Co., Ltd Latest Developments
Table 133. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 134. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Product Offered
Table 135. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Main Business
Table 136. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 137. Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Latest Developments
List of Figures
Figure 1. Peptide CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide CDMO Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Peptide CDMO Market Size Market Share by Type in 2020
Figure 7. Peptide CDMO in Pharmaceutical Industry
Figure 8. Global Peptide CDMO Market: Pharmaceutical Industry (2016-2021) & ($ Millions)
Figure 9. Peptide CDMO in Cosmetics Industry
Figure 10. Global Peptide CDMO Market: Cosmetics Industry (2016-2021) & ($ Millions)
Figure 11. Peptide CDMO in Others
Figure 12. Global Peptide CDMO Market: Others (2016-2021) & ($ Millions)
Figure 13. Global Peptide CDMO Market Size Market Share by Application in 2020
Figure 14. Global Peptide CDMO Revenue Market Share by Player in 2020
Figure 15. Global Peptide CDMO Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Peptide CDMO Market Size 2016-2021 ($ Millions)
Figure 17. APAC Peptide CDMO Market Size 2016-2021 ($ Millions)
Figure 18. Europe Peptide CDMO Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Peptide CDMO Market Size 2016-2021 ($ Millions)
Figure 20. Americas Peptide CDMO Market Size Market Share by Country in 2020
Figure 21. Americas Peptide CDMO Market Size Market Share by Type in 2020
Figure 22. Americas Peptide CDMO Market Size Market Share by Application in 2020
Figure 23. United States Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Peptide CDMO Market Size Market Share by Regions in 2020
Figure 27. APAC Peptide CDMO Market Size Market Share by Type in 2020
Figure 28. APAC Peptide CDMO Market Size Market Share by Application in 2020
Figure 29. China Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Peptide CDMO Market Size Market Share by Country in 2020
Figure 36. Europe Peptide CDMO Market Size Market Share by Type in 2020
Figure 37. Europe Peptide CDMO Market Size Market Share by Application in 2020
Figure 38. Germany Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Peptide CDMO Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Peptide CDMO Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Peptide CDMO Market Size Market Share by Application in 2020
Figure 46. Egypt Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Peptide CDMO Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 52. APAC Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 53. Europe Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 55. United States Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 56. Canada Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 59. China Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 60. Japan Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 61. Korea Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 63. India Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 64. Australia Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 65. Germany Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 66. France Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 67. UK Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 68. Italy Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 69. Russia Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 70. Spain Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 73. Israel Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Peptide CDMO Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Peptide CDMO Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 펩타이드 CDMO 시장예측 2021년-2026년] (코드 : LPI-2201K02264) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 펩타이드 CDMO 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 펩타이드 치료제 시장예측 2021년-2026년
LPI-2201K02265 / LP Information / 2021년 12월 / 본 조사보고서는 펩타이드 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Peptide Therapeutics will have significant change from previous year. By the most conservative estimates of global Peptide Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 31480 million in 2020. Over...

세계의 펩타이드 기반 약물 시장예측 2021년-2026년
LPI-2201K02139 / LP Information / 2021년 12월 / 본 조사보고서는 펩타이드 기반 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Peptide-based Drug will have significant change from previous year. By the most conservative estimates of global Peptide-based Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 31480 million in 2020. Over...

세계의 녹두 펩타이드 시장예측 2021년-2026년
LPI-2201K02926 / LP Information / 2021년 12월 / 본 조사보고서는 녹두 펩타이드의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Mung Bean Peptide will have significant change from previous year. By the most conservative estimates of global Mung Bean Peptide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 모모르디카 카란티아 펩타이드 시장예측 2021년-2026년
LPI-2201K02908 / LP Information / 2021년 12월 / 본 조사보고서는 모모르디카 카란티아 펩타이드의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Momordica Charantia Peptide will have significant change from previous year. By the most conservative estimates of global Momordica Charantia Peptide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 대두 펩타이드 시장예측 2021년-2026년
LPI-2201K03523 / LP Information / 2021년 12월 / 본 조사보고서는 대두 펩타이드의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Soybean Peptide will have significant change from previous year. By the most conservative estimates of global Soybean Peptide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 완두콩 펩타이드 시장예측 2021년-2026년
LPI-2201K03103 / LP Information / 2021년 12월 / 본 조사보고서는 완두콩 펩타이드의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pea Peptide will have significant change from previous year. By the most conservative estimates of global Pea Peptide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 밀 펩타이드 시장예측 2021년-2026년
LPI-2201K03795 / LP Information / 2021년 12월 / 본 조사보고서는 밀 펩타이드의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Wheat Peptide will have significant change from previous year. By the most conservative estimates of global Wheat Peptide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...